Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Shao-Liang Chen
,
Imad Sheiban
Added:
3 years ago
Bifurcation lesions account for approximately 20–30% of all percutaneous coronary interventions (PCIs). Coronary bifurcation sites are prone to developing obstructive atherosclerotic disease due to turbulent blood flow and change of shear stress. With the complexity of bifurcation lesions, several classification systems have been advocated in order to extablish percutaneous strategies.1–3 In fact…
View more
Author(s):
Maciej Lesiak
Added:
3 years ago
While provisional stenting has remained the preferred strategy for majority of bifurcation lesions, controversies still exist regarding when and how to use complex techniques. Most of randomised studies comparing simple and complex approaches have focused on selected populations, included both ‘true’ and ‘non-true’ bifurcation lesions, used first-generation drug eluting stents (DES) and favoured…
View more
Author(s):
Joanna J Wykrzykowska
,
Willem J van der Giessen
Added:
3 years ago
Approach to the Bifurcation Patient
Historically, bifurcation lesions have been associated with lower procedural success and a poorer clinical outcome than non-bifurcation lesions. This may be due to the technical difficulty of the procedure but also due to the complexity of the patients. According to the recently presented LEADERS trial sub-study,1 patients who have bifurcation disease are…
View more
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Author(s):
Mamas A Mamas
,
Farzin Fath-Ordoubadi
Added:
3 years ago
Article
Author(s):
Sandeep Arunothayaraj
Added:
11 months ago
EuroPCR 23 —We are joined onsite by Dr Sandeep Arunothayaraj (University Hospitals Sussex NHS Foundation Trust, UK) to discuss the findings from a five-year follow-up of the EBC Two Trial. (NCT01560455)
EBC Two investigated single-stent versus dual-stent techniques in treating large bifurcation lesions. Over 200 patients were enrolled in the trial.The study found that routine culotte did not…
View more
Author(s):
Jacek Bil
,
Robert Gil
,
Dobrin Vassilev
Added:
8 years ago
Author(s):
Goran Stankovic
,
Zlatko Mehmedbegovic
,
Milorad Zivkovic
Added:
3 years ago
Approximately 15–20% of percutaneous coronary interventions (PCIs) are performed to treat coronary bifurcations. These procedures are renowned for being technically challenging and historically have been associated with lower procedural success rates and worse clinical outcomes compared with non-bifurcation lesions.1,2
A bifurcation lesion is a lesion occurring at, or adjacent to, a significant…
View more
Author(s):
Angela Hoye
,
Scot Garg
Added:
3 years ago
Coronary artery bifurcations are at an increased risk of the development of coronary atherosclerosis because of turbulent flow and low shear stress. Bifurcation lesions account for between 8% and 22% of all percutaneous coronary interventions (PCI) and have long posed a problem for interventional cardiologists.
Published data show bifurcation lesions treated using bare metal stents (BMS) have…
View more
Author(s):
Leif Thuesen
,
Niels Ramsing Holm
Added:
3 years ago
Bifurcation lesions are frequent and account for about 15 % of all percutaneous coronary intervention cases.1 Bifurcations are a challenging lesion subset involving a main vessel (MV) and its side branch (SB). A bifurcation lesion may be looked upon as the proximal MV, the distal main vessel, the SB and the area of the bifurcation. Short- and long-term results depend on optimal handling of all…
View more